← Back to Search

Specimen Ultra-High field MRI for Bladder Cancer

N/A
Waitlist Available
Led By Michael V. Knopp, MD, PhD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

Study Summary

This trial is studying how well a 3 Tesla MRI works in finding cancer in patients with bladder cancer.

Eligible Conditions
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Agreement in tumor staging between pathology and 3 Tesla MRI
Secondary outcome measures
Agreement in lymph node staging between pathology and 3 Tesla MRI

Trial Design

2Treatment groups
Experimental Treatment
Group I: MRI+surgery+chemotherapyExperimental Treatment3 Interventions
3 Tesla MRI/Cystectomy and Lymphadenectomy/Urinary Diversion/Specimen Ultra-High field MRI/chemotherapy
Group II: MRI+surgeryExperimental Treatment2 Interventions
3 Tesla MRI/Cystectomy and Lymphadenectomy/Urinary Diversion/Specimen Ultra-High field MRI
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cystectomy and Lymphadenectomy
2009
N/A
~100
Specimen Ultra-High field MRI
2009
N/A
~100
chemotherapy
2002
Completed Phase 3
~2660

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,296 Total Patients Enrolled
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,069 Total Patients Enrolled
Michael V. Knopp, MD, PhDPrincipal Investigator - Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical experiment currently recruiting participants?

"Contrary to what is hosted on clinicaltrials.gov, this medical trial has concluded its recruitment phase. The undertaking was launched in July of 2009 and last updated in November 2022; however, there are currently 373 additional trials recruiting participants."

Answered by AI
~6 spots leftby Apr 2025